📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Antipsychotic Drugs Companies

Antipsychotic drugs, also known as neuroleptics, are a class of medications primarily used to manage symptoms of psychosis, including schizophrenia, bipolar disorder, and other mental health conditions. These drugs work by modulating the effects of neurotransmitters in the brain, particularly dopamine, which is believed to play a significant role in the development of psychotic symptoms.

Antipsychotic Drugs Key Companies


Latest Antipsychotic Drugs Companies Update

Intra-Cellular Therapies Received FDA approval for Caplyta (lumateperone) as adjunctive therapy for depressive episodes associated with bipolar I or II disorder, expanding its market reach.

Alkermes Announced positive results from ENLIGHTEN-early, a Phase 3b study evaluating LYBALVI for schizophrenia, providing further evidence for its efficacy and tolerability.

Luye Pharma Group Secured FDA approval for Rykindo for the treatment of schizophrenia and bipolar 1 disorder, offering a new option with a once-daily dosing schedule.

Otsuka Pharmaceutical Co., Ltd. and Lundbeck Received FDA approval for Rexulti (brexpiprazole) for the treatment of schizophrenia in adolescents (13-17 years old), addressing a crucial need in this underserved population.

List of Antipsychotic Drugs Key Companies in the Market

  • Johnson and Johnson (U.S.)

  • GlaxoSmithKline Plc. (U.K.)

  • Pfizer Inc. (U.S.)

  • AstraZeneca (U.K.)

  • Bristol-Myers Squibb (U.S.)

  • Eli Lily & Co. (U.S.)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.